Everolimus: Targeted Therapy for Cancer Treatment

 

Benefits:

• Everolimus, a targeted therapy, impedes cancer cell growth.
• Used for treating various cancers:
  • Advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women
  • Progressive neuroendocrine tumors of pancreatic origin
  • Progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal (GI) or lung origin
  • Advanced renal cell carcinoma (RCC)
  • Tuberous sclerosis complex (TSC)-associated renal angiomyolipoma
  • Tuberous sclerosis complex (TSC)-associated subependymal giant cell astrocytoma (SEGA)

Side Effects:

• Common side effects include nausea, vomiting, diarrhea, fatigue, mouth sores, and increased infection risk.
• Serious side effects may include bone marrow suppression, liver/kidney damage, diabetes, or heart failure.

Precautions:

• Avoid use during pregnancy or breastfeeding.
• Use cautiously with a history of specific health conditions.
• Close monitoring for side effects recommended.

Dosage:

• Individualized dosage as prescribed by the doctor based on cancer type and patient condition.

Storage:

• Store this tablets at room temperature in a dry place.

Overdose:

• In case of suspected overdose, contact the doctor or poison control immediately.

Drug Interactions:

• This medicine may interact with various medications, including cyclosporine, tacrolimus, steroids, and antibiotics.

Patient Information:

• Awareness about potential serious side effects and close monitoring is crucial.
• Pregnancy, breastfeeding, or specific health histories warrant caution with its use.